Lunit and Leeds Teaching Hospitals NHS Trust plan to launch a prospective AI study among symptomatic breast clinic patients.
The study will use Lunit's Insight MMG and will seek to establish the system's efficacy when used with a human reader compared with a double human reading. It will run through the end of 2025 and will include 5,500 mammography cases, the company said. Participants will be divided into two groups: One group of 2,750 women whose exams will be interpreted via traditional double reading and another group of 2,750 women whose exams will be read by two radiologists aided by Lunit Insight MMG.
